Qube Research & Technologies (QRT)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-63,424
Closed -$552K 3945
2025
Q2
$552K Sell
63,424
-294,755
-82% -$2.14M ﹤0.01% 2659
2025
Q1
$2.85M Buy
358,179
+337,632
+1,643% +$3.42M ﹤0.01% 1814
2024
Q4
$187K Sell
20,547
-702,052
-97% -$6.78M ﹤0.01% 2851
2024
Q3
$6.63M Sell
722,599
-943,227
-57% -$7.81M 0.01% 1255
2024
Q2
$16.3M Buy
1,665,826
+1,194,124
+253% +$14.6M 0.03% 696
2024
Q1
$7.12M Buy
471,702
+105,279
+29% +$1.91M 0.01% 1025
2023
Q4
$7.9M Sell
366,423
-1,276,259
-78% -$23.5M 0.02% 830
2023
Q3
$30.5M Buy
1,642,682
+516,498
+46% +$12.1M 0.08% 307
2023
Q2
$28.5M Buy
1,126,184
+556,983
+98% +$14M 0.1% 261
2023
Q1
$14.7M Buy
+569,201
New +$15.2M 0.06% 338
2022
Q3
Sell
-11,330
Closed -$376K 3018
2022
Q2
$376K Buy
+11,330
New +$481K ﹤0.01% 1524
2020
Q4
Sell
-6,632
Closed -$1.45M 2190
2020
Q3
$1.45M Sell
6,632
-115,390
-95% -$24.4M 0.02% 717
2020
Q2
$23.3M Buy
122,022
+106,817
+703% +$18.7M 0.34% 46
2020
Q1
$2.36M Buy
+15,205
New +$1.77M 0.1% 201

Other funds holding TDOC

Qube Research & Technologies (QRT)'s TDOC Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 63,424 shares — an estimated $552K sold.

Qube Research & Technologies (QRT) first reported a position in TDOC in Q1 2020 and held it in 14 quarters. The position peaked at $30.5M in Q3 2023. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 63,424 Teladoc Health shares in Q3 2025, an estimated $552K.
  • Qube Research & Technologies (QRT) first reported a position in Teladoc Health in Q1 2020 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s Teladoc Health position peaked at $30.5M in Q3 2023.
  • 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.